BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27311963)

  • 1. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
    Mularoni L; Sabarinathan R; Deu-Pons J; Gonzalez-Perez A; López-Bigas N
    Genome Biol; 2016 Jun; 17(1):128. PubMed ID: 27311963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNCDatabase: a database of non-coding cancer drivers.
    Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
    Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide mapping of somatic mutation rates uncovers drivers of cancer.
    Sherman MA; Yaari AU; Priebe O; Dietlein F; Loh PR; Berger B
    Nat Biotechnol; 2022 Nov; 40(11):1634-1643. PubMed ID: 35726091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer regulatory variation.
    Hennessey RC; Brown KM
    Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of coding and non-coding mutational hotspots in cancer genomes.
    Piraino SW; Furney SJ
    BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for cancer vulnerabilities amid genetic chaos.
    Speicher MR
    Genome Biol; 2017 Aug; 18(1):147. PubMed ID: 28768521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features.
    Lanzós A; Carlevaro-Fita J; Mularoni L; Reverter F; Palumbo E; Guigó R; Johnson R
    Sci Rep; 2017 Jan; 7():41544. PubMed ID: 28128360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolution and Expression Pattern of Human Overlapping lncRNA and Protein-coding Gene Pairs.
    Ning Q; Li Y; Wang Z; Zhou S; Sun H; Yu G
    Sci Rep; 2017 Mar; 7():42775. PubMed ID: 28344339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events.
    Li J; Poursat MA; Drubay D; Motz A; Saci Z; Morillon A; Michiels S; Gautheret D
    PLoS Comput Biol; 2015 Nov; 11(11):e1004583. PubMed ID: 26588488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying tumorigenic non-coding mutations through altered
    Cheng Z; Vermeulen M; Rollins-Green M; Babak T; DeVeale B
    STAR Protoc; 2021 Dec; 2(4):100934. PubMed ID: 34816127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of epigenetic marks and transcription factor binding sites across promoters of sense-intronic long noncoding RNAs.
    Ghosh S; Sati S; Sengupta S; Scaria V
    J Genet; 2015 Mar; 94(1):17-25. PubMed ID: 25846873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the exome: the role of non-coding somatic mutations in cancer.
    Piraino SW; Furney SJ
    Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CScape: a tool for predicting oncogenic single-point mutations in the cancer genome.
    Rogers MF; Shihab HA; Gaunt TR; Campbell C
    Sci Rep; 2017 Sep; 7(1):11597. PubMed ID: 28912487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathway and network analysis of more than 2500 whole cancer genomes.
    Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
    Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
    Yan X; Hu Z; Feng Y; Hu X; Yuan J; Zhao SD; Zhang Y; Yang L; Shan W; He Q; Fan L; Kandalaft LE; Tanyi JL; Li C; Yuan CX; Zhang D; Yuan H; Hua K; Lu Y; Katsaros D; Huang Q; Montone K; Fan Y; Coukos G; Boyd J; Sood AK; Rebbeck T; Mills GB; Dang CV; Zhang L
    Cancer Cell; 2015 Oct; 28(4):529-540. PubMed ID: 26461095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
    Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
    Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FABRIC Cancer Portal: A Ranked Catalogue of Gene Selection in Tumors Over the Human Coding Genome.
    Kelman G; Brandes N; Linial M
    Cancer Res; 2021 Feb; 81(4):1178-1185. PubMed ID: 33277365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
    Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
    BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mining the coding and non-coding genome for cancer drivers.
    Li J; Drubay D; Michiels S; Gautheret D
    Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.